Wei Ranran, Ding Kun, Zhang Shan, Cao Zhe, Liang Xiaoqin
Shandong Second Medical University, Weifang city, Shandong Province, China.
J Craniofac Surg. 2024 Jul 29;35(8):e718-22. doi: 10.1097/SCS.0000000000010486.
To study the clinical effect of conjoint fascial sheath (CFS) suspension and levator palpebrae superioris muscle shortening in the treatment of severe blepharoptosis.
Forty-five patients with severe blepharoptosis (75 eyes) from May 2020 to February 2022 in the authors' hospital were divided into 2 groups: group A (n = 33, 43 eyes) and group B (n = 24, 32 eyes). Group A was operated on by CFS + levator muscle shortening, and group B was operated on by frontal muscle flap suspension + levator muscle shortening. Both groups were followed up for 12 months (until February 2023). The clinical effect was counted in 6 months after operation, the early complications were counted in 1 month after operation, and the late complications were counted in 1 month to 12 months after operation. Margin to corneal reflex distance 1 (MRD1) and palpebral fissure height (PFH) were recorded before, 1 week, 3 months, and 12 months postoperatively, and the amount of eyelid retrogression was counted again.
The good correction rate was 90.70% in group A, higher than in group B (71.88%), and the difference was statistically significant (P< 0.05); the early postoperative complication rate was 9.30%, lower than in group B (24.38%), and the difference was statistically significant (P< 0.05); the late postoperative complication rate was 2.33%, lower than group B (18.75%), and the difference was statistically significant (P< 0.05). The MRD1 and PFH of group A were higher than those of group B (P< 0.05) at 3 months postoperatively and 12 months postoperatively; the MRD1 and PFH of group A were lower than those of group B (P< 0.05) at 3 months postoperatively and 12 months postoperatively. Repeated measurement analysis of variance showed that there were significant differences in the main effects of MRD1, PFH, eyelid retrogression, and time in group A and group B (P< 0.05), and there was interaction between intervention and time (P< 0.05).
Conjoint fascial sheath suspension combined with levator palpebrae superioris muscle shortening can effectively improve MRD1 and PFH, and the amount of upper eyelid retraction is controllable 1 year after operation.
探讨联合筋膜鞘(CFS)悬吊术与提上睑肌缩短术治疗重度上睑下垂的临床效果。
选取2020年5月至2022年2月在作者所在医院就诊的45例重度上睑下垂患者(75只眼),分为A组(n = 33,43只眼)和B组(n = 24,32只眼)。A组采用CFS + 提上睑肌缩短术,B组采用额肌瓣悬吊术 + 提上睑肌缩短术。两组均随访12个月(至2023年2月)。术后6个月统计临床效果,术后1个月统计早期并发症,术后1个月至12个月统计晚期并发症。记录术前、术后1周、3个月和12个月时的角膜反射缘与上睑缘距离1(MRD1)及睑裂高度(PFH),再次统计上睑退缩量。
A组良好矫正率为90.70%,高于B组(71.88%),差异有统计学意义(P < 0.05);术后早期并发症发生率为9.30%,低于B组(24.38%),差异有统计学意义(P < 0.05);术后晚期并发症发生率为2.33%,低于B组(18.75%),差异有统计学意义(P < 0.05)。术后3个月和12个月时,A组的MRD1和PFH均高于B组(P < 0.05);术后3个月和12个月时,A组的MRD1和PFH均低于B组(P < 0.05)。重复测量方差分析显示,A组和B组在MRD1、PFH、上睑退缩及时间的主效应方面存在显著差异(P < 0.05),干预与时间之间存在交互作用(P < 0.05)。
联合筋膜鞘悬吊联合提上睑肌缩短术可有效改善MRD1和PFH,术后1年上睑退缩量可控。